NCT00187083View on ClinicalTrials.gov

A Study of Children With Refractory or Relapsed ALL

PHASE3CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

February 28, 1997

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions

Acute Lymphoblastic Leukemia

Interventions

DRUG

Topotecan, dexamethasone, vincristine

See Detailed Description section for details of treatment interventions.

DRUG

E. coli Asparaginase, PEG-L-asparaginase

See Detailed Description section for details of treatment interventions.

DRUG

erwinia asparaginase

See Detailed Description section for details of treatment interventions.

DRUG

fludarabine, methotrexate, mercaptopurine

See Detailed Description section for details of treatment interventions.

DRUG

idarubicin, etoposide, cytarbine, teniposide

See Detailed Description section for details of treatment interventions.

PROCEDURE

chemotherapy, intrathecal chemotherapy, steroid therapy

See Detailed Description section for details of treatment interventions.

Trial Locations (1)

38105

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors

lead

St. Jude Children's Research Hospital

OTHER

NCT00187083 - A Study of Children With Refractory or Relapsed ALL | Biotech Hunter | Biotech Hunter